Last week, the project consortium gathered at Hovione’s facilities in Lisbon for a two-day meeting dedicated to collaboration, progress review, and planning the next steps. Photo credit: Hovione

Ich spreche in zwei Wochen in dieser wunderbaren allgemeinenverständlichen Vortragsreihe über unsere Forschung! Vor Ort und Online ! bi.mpg.de/wws

Great lab, great opportunity!

This meeting looks very interesting, so don't miss the abstract submission deadline. Suzhou is indeed a beautiful location. I was there in April for the CSHA transposon meeting, as you can see my photo visiting Yogita's (from @JakobssonLab ) poster used as a cover image here 😅

This goes to all of you, who are interested in cell fate and reprogramming ! If you want to present your research among an incredible line-up, please register soon! meetings.cshl.edu/meetings.a…

1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl

youtu.be/WHTg7YsrUSw?si=PorW… Cool video-podcast of my Student Tobi... 👍👍👍

Check out our new review 👇

Likely the best meeting of the year! meetings.cshl.edu/meetings.a…

🌟 What makes the Stem Cell Center unique? The Stem Cell Center at #HelmholtzMunich is globally outstanding in its combination of expertise across stem cells, developmental mechanisms, cell plasticity, and epigenetics. This fusion enables the research on reprogramming of local cells to regenerate lost identities in adult organs, such as the brain and pancreas, where stem cells are either scarce or nonexistent. • Unmatched expertise in stem cells and epigenetics • Next-level reprogramming techniques • Translating research into regenerative therapies 🌟 Want to learn more? Visit our website! 👉 t1p.de/eoemr #StemCellResearch #RegenerativeMedicine #Epigenetics

🔬 Science Through an Artistic Lens🎨 👉t1p.de/j5pi8 🧬Blending creativity with cutting-edge research, the #RepliFate Artist-in-Residence Program unites artists and scientists to explore DNA replication and its role in cell fate and cancer. Led by Prof. Maria-Elena Torres-Padilla, the program opens new dimensions of thinking – merging the worlds of art and science in unexpected ways. The initiative invites artists into laboratories, allowing them to collaborate directly with researchers and engage with advanced technologies. ✨Bioartist Anna Dumitriu was the first artist-in-residence at the Institute of Epigenetics & Stem Cells at #HelmholtzMunich. Now, three new artists continue the journey with residencies running throughout 2024-2025, curated by Dr. Claudia Schnugg. 🖼️ From Bench to Gallery: Their final works will be unveiled at the RepliFate Conference in 2026. 💬 “This program fosters creativity, out-of-the-box thinking, and a broader societal understanding of our science.” – Maria-Elena Torres-Padilla @METorresPadilla @epigeneticsHMGU @AnnaDumitriu @EU_Commission @FateRepli @MSCActions #ArtScience #ArtistInResidence #Epigenetics #MSCActions #BioArt

Check out our paper, now extensively revised and published in @MolecularCell! This has been a real tour de force led by @stephsansbury and @YSereb and we are very excited about the findings and future potential of this approach cell.com/molecular-cell/abst…

Stefan Stricker - group leader at the Helmholtz Munich and Professor at Biomedical Center (BMC) LMU Munich explores gene editing and gene reprogramming. 📽️ Watch the podcast here youtube.com/watch?v=C0qqsYBV… #Regenerar #BrainRegeneration #DiseaseTreatment

A Safer, More Precise Way to Control Genes: Introducing dRNPs 🧬 👉t1p.de/f099l Researchers at #HelmholtzMunich, in collaboration with the Helmholtz Protein Expression and Purification Platform (PEPP), have developed a CRISPR-based technology that activates genes without using DNA or viruses. This method – based on dRNPs (dCas9-VPR ribonucleoprotein complexes) – marks a significant leap forward for gene therapy and regenerative medicine, offering a safe, fast, and highly precise alternative to traditional approaches. 💡 What makes dRNPs different? ✅ DNA- and virus-free ✅ Transient and efficient gene activation ✅ Applicable to various human cell types ✅ Capable of activating multiple genes simultaneously 💬“dRNPs are a completely new option to treat cells in a disease context. Since the technology does not induce mutations and is DNA- and virus-free, we have great hopes for its future application in therapeutic contexts.” – Prof. Stefan Stricker, senior author of the study ✨ This innovation sets a new standard in gene modulation – paving the way for safer, more effective treatments. @LabStricker @LMU_Muenchen @epigeneticsHMGU #CRISPR #GeneTherapy #RegenerativeMedicine

New Ambrozkiewicz Lab preprint! 🧠 Ubiquitin – m6A axis controls brain development 👶 Loss of UBE3C → too many neurons, not enough glia 💊 Fixed with METTL3 inhibition We have the mechanism, the concept and the therapeutic lead. 📄 biorxiv.org/content/10.1101/…

On March 31st and April 1st, REGENERAR partners gathered at the Biomedical Center, Physiological Genomics, Faculty of Medicine, Ludwig-Maximilians-Universität München for a productive and insightful meeting. Looking forward to the exciting next steps in regenerative medicine. 🧬

Let's do CRISPRa without virus and plasmids!!! Congratulations to Tobi and all the authors ! It was a really fun project, revealing some exciting results! academic.oup.com/nar/article…

Exciting @GermanStemCell workshop on computational approaches in single cell genomics in stem cell research! 🧬🔬 With Sara and Tim, two trainer from the lab, this’ll be fun! More info & registration here: gscn.org/conferences-events/… 🌟